|
Diabetes, Vol 49, Issue 7 1142-1148, Copyright © 2000 by American Diabetes Association
Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression
N Ban, Y Yamada, Y Someya, Y Ihara, T Adachi, A Kubota, R Watanabe, A Kuroe, A Inada, K Miyawaki, Y Sunaga, ZP Shen, T Iwakura, K Tsukiyama, S Toyokuni, K Tsuda and Y Seino
Department of Metabolism and Clinical Nutrition, Graduate School of Medicine, Kyoto University, Japan.
Insulin plays a crucial role in the regulation of glucose-homeostasis, and
its synthesis is regulated by several stimuli. The transcription of the
human insulin gene, enhanced by an elevated intracellular concentration of
calcium ions, was completely blocked by Ca2+/calmodulin-dependent protein
kinase inhibitor. The activity of the transcription factor activating
transcription factor-2 (ATF-2), which binds to the cAMP responsive elements
of the human insulin gene, was enhanced by Ca2+/calmodulin-dependent
protein kinase IV (CaMKIV). Mutagenesis studies showed that Thr69, Thr71,
and Thr73 of ATF-2 are all required for activation by CaMKIV.
CaMKIV-induced ATF-2 transcriptional activity was not altered by activation
of cJun NH2-terminal protein kinase (JNK) or p38 mitogen-activated protein
(MAP) kinase. Furthermore, when transfected into rat primary cultured
islets, ATF-2 enhanced glucose-induced insulin promoter activity, whereas
cAMP response element-binding protein (CREB) repressed it. These results
suggest a mechanism in which ATF-2 regulates insulin gene expression in
pancreatic beta-cells, with the transcriptional activity of ATF-2 being
increased by an elevated concentration of calcium ions.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Baan, H. van Dam, G. C. M. van der Zon, J. A. Maassen, and D. M. Ouwens
The Role of c-Jun N-Terminal Kinase, p38, and Extracellular Signal-Regulated Kinase in Insulin-Induced Thr69 and Thr71 Phosphorylation of Activating Transcription Factor 2
Mol. Endocrinol.,
August 1, 2006;
20(8):
1786 - 1795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Storling, S. V. Zaitsev, I. L. Kapelioukh, A. E. Karlsen, N. Billestrup, P.-O. Berggren, and T. Mandrup-Poulsen
Calcium Has a Permissive Role in Interleukin-1{beta}-Induced c-Jun N-Terminal Kinase Activation in Insulin-Secreting Cells
Endocrinology,
July 1, 2005;
146(7):
3026 - 3036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Khidekel, S. B. Ficarro, E. C. Peters, and L. C. Hsieh-Wilson
Exploring the O-GlcNAc proteome: Direct identification of O-GlcNAc-modified proteins from the brain
PNAS,
September 7, 2004;
101(36):
13132 - 13137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sevilla, C. R. Santos, F. M. Vega, and P. A. Lazo
Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK
J. Biol. Chem.,
June 25, 2004;
279(26):
27458 - 27465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yu, K. Murao, Y. Sayo, H. Imachi, W. M. Cao, S. Ohtsuka, M. Niimi, H. Tokumitsu, H. Inuzuka, N. C.W. Wong, et al.
The Role of Calcium/Calmodulin-Dependent Protein Kinase Cascade in Glucose Upregulation of Insulin Gene Expression
Diabetes,
June 1, 2004;
53(6):
1475 - 1481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hong, H. M. Choi, M. J. Park, Y. H. Kim, Y. H. Choi, H. H. Kim, Y. H. Choi, and J. Cheong
Activation and Interaction of ATF2 with the Coactivator ASC-2 Are Responsive for Granulocytic Differentiation by Retinoic Acid
J. Biol. Chem.,
April 23, 2004;
279(17):
16996 - 17003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Quesada, F. Martin, E. Roche, and B. Soria
Nutrients Induce Different Ca2+ Signals in Cytosol and Nucleus in Pancreatic {beta}-Cells
Diabetes,
February 1, 2004;
53(90001):
S92 - 95.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Gadal, C. Bozic, C. Pillot-Brochet, S. Malinge, S. Wagner, A. Le Cam, L. Buffat, M. Crepin, and F. Iris
Integrated transcriptome analysis of the cellular mechanisms associated with Ha-ras-dependent malignant transformation of the human breast epithelial MCF7 cell line
Nucleic Acids Res.,
October 1, 2003;
31(19):
5789 - 5804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jambal, S. Masterson, A. Nesterova, R. Bouchard, B. Bergman, J. C. Hutton, L. M. Boxer, J. E.-B. Reusch, and S. Pugazhenthi
Cytokine-mediated Down-regulation of the Transcription Factor cAMP-response Element-binding Protein in Pancreatic {beta}-Cells
J. Biol. Chem.,
June 13, 2003;
278(25):
23055 - 23065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. G. Chepurny, M. A. Hussain, and G. G. Holz
Exendin-4 as a Stimulator of Rat Insulin I Gene Promoter Activity via bZIP/CRE Interactions Sensitive to Serine/Threonine Protein Kinase Inhibitor Ro 31-8220
Endocrinology,
June 1, 2002;
143(6):
2303 - 2313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Lawrence, H. S. Bhatt, and R. A. Easom
NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1
Diabetes,
March 1, 2002;
51(3):
691 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kemp and J. F. Habener
Insulinotropic Hormone Glucagon-Like Peptide 1 (GLP-1) Activation of Insulin Gene Promoter Inhibited by p38 Mitogen-Activated Protein Kinase
Endocrinology,
March 1, 2001;
142(3):
1179 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|